Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.900
+0.060 (3.26%)
At close: Aug 4, 2026, 4:00 PM EDT
1.920
+0.020 (1.05%)
Pre-market: Aug 5, 2026, 9:06 AM EDT
Allogene Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
152
Market Cap
655.79M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 22.00K | -73.00K | -76.84% |
| Dec 31, 2023 | 95.00K | -61.00K | -39.10% |
| Dec 31, 2022 | 156.00K | -113.93M | -99.86% |
| Dec 31, 2021 | 114.09M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| MiMedx Group | 355.17M |
| Zevra Therapeutics | 122.29M |
| REGENXBIO | 87.82M |
| Crescent Biopharma | 11.88M |
| Neurogene | 925.00K |
ALLO News
- 1 day ago - Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update - GlobeNewsWire
- 7 days ago - Allogene gets RMAT, Fast Track designations for cemacabtagene ansegedleucel - TheFly
- 7 days ago - Allogene Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Cemacabtagene Ansegedleucel (Cema-Cel) as First-Line Consolidation Therapy for Large B-Cell Lymphoma - GlobeNewsWire
- 21 days ago - Allogene publishes Phase 1 data in Journal of Clinical Oncology - TheFly
- 21 days ago - Allogene Therapeutics Announces Journal of Clinical Oncology Publication of Phase 1 Results of ALLO-316 Highlighting First Durable Remissions Following Allogeneic CAR T for Treatment of Metastatic Solid Tumors - GlobeNewsWire
- 5 weeks ago - Allogene Therapeutics Transcript: H.C. Wainwright 4th Annual Cell Therapy Virtual Conference - Transcripts
- 6 weeks ago - Allogene Therapeutics Transcript: AGM 2026 - Transcripts
- 2 months ago - Allogene Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts